Antibacterial Resistance Menace: A Global Cause of Concern?
DOI:
https://doi.org/10.55677/IJCSMR/V2I9-01/2022Keywords:
Antibacterial resistance, Antibiotic- emergence, Global survillance, Antibiotic menaceAbstract
Antibacterial resistance (ABR) is defined as bacteria that are not inhibited by an agent's usually achievable systemic concentration with a standard dosage schedule and fall in the minimum inhibitory concentration ranges. ABR act as a major threat by the World Health Organization (WHO) due to the lack of new antibiotics in the development pipeline and infections caused by multi-drug resistant pathogens becoming untreatable. ABR posed a major threat to human health around the world and occurs when changes in bacteria reduce or eliminate the potency of drugs or chemicals designed to treat or prevent the infection. This systematic review discussing the true burden of resistance, particularly in developing countries where surveillance is minimal and data are sparse, its method of spread, and ways to prevent ABR. GLASS developed by WHO monitors progress in implementing national surveillance systems worldwide and fosters the standardized collection, analysis, and sharing of official data on ABR and antimicrobial consumption (AMC), as well as information on crucial ABR epidemiological indicators.
References
Tortora JG. Microbiology: an introduction. 7th ed. Redwood City, CA: The Benjamín Cummin Publishing Company; 2001. p. 491–509.
Arakawa Y. Epidemiology of drug-resistance and clinical microbiologists in the 21st century. Rinsho Byron. 2000 Jan; Suppl 111:1-8.
Lynn L. Silver. (2011). Challenges of Antibacterial Discovery. Clin Microbiol Rev. 2011 Jan; 24(1): 71–109.
http://www.independent.co.uk/life-style/health-and-families/health-news/first-new-antibiotic-in-30-years-could-bekey- to-beating-superbug-resistance-9963585.html.
O'Neill J. Tackling drug-resistant infections globally: final report and recommendations. London: Review on Antibacterial resistance, 2016.
O'Neill J. Antibacterial resistance: tackling a crisis for the health and wealth of nations. London: Review on Antibacterial resistance, 2014.
Bari SB, Mahajan BM, Surana SJ. Resistance to an antibiotic: A challenge in chemotherapy. Indian Journal of Pharmaceutical Education and Research 2008; 42 (1): 3-11.
Roger FG, Greenwood D, Norbby SR, Whitley RJ. Antibiotic and Chemotherapy, The problem of Resistance, 8th ed. Churchill Livingstone; 2003. p. 25 – 47.
Tripathi KD. Essentials of Medical Pharmacology, Antimicrobial Drugs: General Consideration, 5th ed. Jaypee brother's Medical publishers (P) Ltd; 2003. P.627-640.
Bacterial Resistance to antibiotics, 2008 Kenneth Todar University of Wisconsin- Madison Department of Bacteriology.
(http://www.textbookofbacteriology.net/ resantimicrobial.html)
US Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, 2019.
Cassini A, Högberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibioticresistant bacteria in the E.U. and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis 2019; 19: 56–66.
Lim C, Takahashi E, Hongsuwan M, et al. Epidemiology and burden of multidrug-resistant bacterial infection in a developing country. eLife 2016; 5: e18082
Temkin E, Fallach N, Almagor J, Gladstone BP, Tacconelli E, Carmeli Y. Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study. Lancet Glob Health 2018; 6: e969–79.
O'Neill J. Tackling drug-resistant infections globally: final report and recommendations. Review on Antibacterial resistance; 2016. Available from: https://ABR-review.org/ sites/default/files/160518_Final%20paper_with%20cover. pdf, accessed on April 15, 2017.
O'Neill J. Antibacterial resistance: Tackling a crisis for the health and wealth of nations. Review on Antibacterial resistance; 2020.
World Health Organization, Regional Office for South-East Asia. Jaipur declaration on Antibacterial resistance; 2011. http://www.who.int/iris/handle/10665/205397, accessed on April 15, 2017.
Smith E, Lichten CA, Taylor J, MacLure C, Lepetit L, Harte E, et al. Evaluation of the action plan against the rising threats from Antibacterial resistance. Final Report. European Commission; 2016. Available from: https://www.ec.europa. EU/health/ABR/sites/ABR/files/ABR_final-report_2016_rand. pdf, accessed on April 15, 2017.
Department of Health, Department for Environment Food and Rural Affairs. U.K. Five Year Antibacterial resistance Strategy 2013 to 2018. Government of U.K.; 2013. Available from: HTTPS:// www.gov.uk/government/publications/uk-5-year-antimicrobialresistance-strategy-2013-to-2018, accessed on April 15, 2017.
Government of India. National Action Plan on Antibacterial resistance (NAP-ABR) 2017 - 2021; 2017. Available from: http://www.searo.who.int/india/topics/antimicrobial_ resistance/nap_ABR.pdf, accessed on April 15, 2017.
Higgins J, Green S. Cochrane handbook for systematic reviews of interventions, version 5.1.0. West Sussex, Wiley-Blackwell, A John Wiley & Sons, Ltd, 2011.
GA Wells BS, D O'Connell, J Peterson, V Welch, M Losos, P Tugwell, The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. www.medecine.mcgill.ca, 2000.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Letter Y, Alonso-Coello P et al. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical Research Ed.), 2008, 336(7650):924-926. (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_ uids=18436948, accessed 29 January 2014).
Center for disease control and prevention. https://www.cdc.gov/drugresistance/index.html.
WHO. Global Antibacterial resistance and use surveillance system (GLASS) report Early implementation 2020. 2020 (https://apps.who.int/iris/bitstream/hand le/10665/332081/9789240005587-eng.pdf, accessed 08/04/2021
WHO. GLASS whole-genome sequencing for surveillance of Antibacterial resistance. 2020 (https://cms.who.int/publications/i/item/9789240011007, accessed 08/04/2021
WHO. GLASS guidance for national reference laboratories. 2020 (https://cms.who.int/publications/i/item/9789240010581, accessed 08/04/2021.
